Advertisement

Participation of Cytoskeletal Elements in Neuronal Signal Transduction: New Insight into the Molecular Basis of Antidepressant Action

  • Shinichi Hatta
  • Hideyo Ohshika
Conference paper

Abstract

Antidepressant drugs have been used clinically not only for depression but also for other psychiatric disorders. Despite extensive studies, the mechanisms of action of antidepressant drugs have not been clearly established. The classic monoamine hypothesis of depression suggests that depressive disorders are associated with subnormal monoamine release at certain synapses of the CNS. Antidepressant drugs are supposed to increase the availability of noradrenaline and serotonin, either by inhibiting amine reuptake or by blocking monoamine oxidase in presynaptic nerve terminals, and facilitate monoamine transmission (Schildkraut 1965). However, an acute effect of antidepressants on neurotransmission is inconsistent with the delayed onset of clinical efficacy of these drugs (Zemlan and Garver 1990). Furthermore, neuroleptic drugs such as amphetamine and cocaine that block reuptake or catabolism of monoamines do not have an antidepressant effect. Thus, an acute neurochemical effect of antidepressant drugs may not account for the mechanism of action of these drugs.

Keywords

Adenylate Cyclase Adenylyl Cyclase Antidepressant Drug Guanine Nucleotide Adenylyl Cyclase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amir-Zaltsman Y, Ezra E, Scherson T, Zutra A, Littauer UZ, Salomon Y (1982) ADP- ribosylation of microtubule proteins as catalyzed by cholera toxin. EMBO J 1: 181–186PubMedGoogle Scholar
  2. Bhattacharyya B, Sackett DL, Wolff J (1985) Tubulin, hybrid dimers and tubulin S: stepwise charge reduction and polymerization. J Biol Chem 260: 10208–10216PubMedGoogle Scholar
  3. Chen J, Rasenick MM (1995a) Chronic treatment of C6 glioma cells with antidepres¬sant drugs increases functional coupling between a G protein ( Gs) and adenylyl cyclase. J Neurochem 64: 724–732Google Scholar
  4. Chen J, Rasenick MM (1995b) Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J Pharmacol Exp Ther 275: 509–517PubMedGoogle Scholar
  5. Cowburn RF, Marcusson JO, Eriksson A, Wiehager B, ONeill C (1994) Adenylyl cyclase and G protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res 633: 297–304PubMedCrossRefGoogle Scholar
  6. De Montis GM, Devoto P, Gessa GL, Procella A, Serra G, Tagliamonte A (1990) Selective adenylate cyclase increase in the limbic area of long-term imipramine- treated rats. Eur J Pharamcol 180: 169–174CrossRefGoogle Scholar
  7. Hagmann J, Fishman PH (1980) Modulation of adenylate cyclase in intact macrophage by microtubules: opposing actions of colchicine and chemotactic factor. J Biol Chem 255: 2659–2662PubMedGoogle Scholar
  8. Hatta S, Ameniya N, Ohshika H, Saito T, Ozawa H (1992) Tubulin modifies neuronal sinal transduction through the association with G-proteins in rat cerebral cortex and striatum. Soc Neurosci Abstr 18: 285Google Scholar
  9. Hatta S, Ozawa H, Saito T, Ohshika H (1994) Alteration of tubulin-Gi protein interac¬tion in rat cerebral cortex with aging. J Neurochem 63: 1104–1110PubMedCrossRefGoogle Scholar
  10. Hatta S, Ozawa H, Saito T, Ohshika H (1995a) Participation of tubulin in the stimula¬tory regulation of adenylyl cyclase in rat cerebral cortex membranes. J Neurochem 64: 1343–1350PubMedCrossRefGoogle Scholar
  11. Hatta S, Ozawa H, Saito T, Ameniya N, Ohshika H (1995b) Tubulin stimulates adenylyl cyclase activity in rat striatal membranes via transfer of guanine nucleotide to Gs protein. Brain Res 704: 23–30PubMedCrossRefGoogle Scholar
  12. Jameson L, Caplow M (1981) Modification of microtubule steady-state dynamics by phosphorylation of the microtubule-associated proteins. Proc Natl Acad Sci USA 78: 3413–3417PubMedCrossRefGoogle Scholar
  13. Jameson L, Frey T, Zeeberg B, Dalldorf F, Caplow M (1980) Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins. Biochemistry 19: 2472–2479PubMedCrossRefGoogle Scholar
  14. Kamada H, Ozawa H, Saito T, Hatta S, Takahata N (1997) Dimeric tubulin-stimulated adenylyl cyclase activity is augmented after long-term amitriptyline treatment. Life Sci 60: 57–66PubMedCrossRefGoogle Scholar
  15. Kennedy MS, Insel PA (1979) Inhibitors of microtubule assembly enhance beta- adrenergic and prostaglandin Erstimulated cyclic accumulation in S49 lymphoma cells. Mol Pharmacol 16: 215–223PubMedGoogle Scholar
  16. Kim H, Jensen C, Rebhun L (1986) The binding of MAP-2 and tau on brain microtu¬bules in vitro: implications for microtubule structure. Ann NY Acad Sci 466: 218–239PubMedCrossRefGoogle Scholar
  17. Lim L-K, Sekura RD, Kaslow HR (1985) Adenine nucleotides directly stimulate pertussis toxin. J Biol Chem 260: 2585–2588PubMedGoogle Scholar
  18. Littauer U, Giveon D, Thierauf M, Ginsburg I, Postingl H (1985) Tubulin binding sites for microtubule associated proteins. In: De Brabander M, De Mey J (eds) Microtubules and microtubule inhibitors 1985. Elsevier Science Publishers B.V., Amsterdam, pp 171–176Google Scholar
  19. Maccioni R, Serrono L, Avila J (1985) Structural and functional domains of tubulin. BioEssays 4: 165–169Google Scholar
  20. Menkes DB, Rasenick MM, Wheeler MA, Bitensky NW (1983) Guanosine triphos-phate activation of brain adenylate cyclase: enhancement by long-term antidepres¬sant treatment. Science 219: 65–67PubMedCrossRefGoogle Scholar
  21. Miyamoto S, Asakura M, Sasuga Y (1995) Effect of chronic administration of antide¬pressants on microtubule assembly in rat cerebral cortex. Jpn J Psychopharmacol 15:385–395 (abstract in English)Google Scholar
  22. Newman ME, Lerer B (1989) Post-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitization. Eur J Pharmacol 162: 345–352PubMedCrossRefGoogle Scholar
  23. Ozawa H, Rasenick MM (1989) Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 36: 803–808PubMedGoogle Scholar
  24. Ozawa H, Rasenick MM (1991) Chronic electroconvulsive treatment augments cou¬pling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 56: 330–338PubMedCrossRefGoogle Scholar
  25. Ozawa H, Katamura Y, Hatta S, Amemiya N, Saito T, Ohshika H, Takahata N (1994) Antidepressants directly influence in situ binding of guanine nucleotide in synaptic membrane. Life Sci 54: 925–932PubMedCrossRefGoogle Scholar
  26. Perez J, Tinelli D, Brunello N, Racagni G (1989) cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol Mol Pharmacol Sec 172: 305–316Google Scholar
  27. Popova JS, Garrison JC, Rhee SG, Rasenick MM (1997) Tubulin, Gq, and phos- phatidylinositol 4,5-bisphosphate interact to regulate phospholipase Cp! signaling. J Biol Chem 272: 6760–6765PubMedCrossRefGoogle Scholar
  28. Rasenick MM, Wang N (1988) Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction. J Neurchem 51: 300–311CrossRefGoogle Scholar
  29. Rasenick MM, Stein P, Bitensky MW (1981) The regulatory subunit of adenylate cyclase interacts with cytoskeletal components. Nature 294: 560–562PubMedCrossRefGoogle Scholar
  30. Rasenick MM, O’Callahan CM, Moore CA, Kaplan RS (1985) GTP-binding proteins which regulate neuronal adenylate cyclase interact with microtubule proteins. In: De Brabander M, De Mey J (eds) Microtubules and microtubule inhibitors 1985. Elsevier Science Publishers B.V., Amsterdam, pp 313–323Google Scholar
  31. Roychowdhury S, Wang N, Rasenick MM (1994) Tubulin-G protein association stabi¬lizes GTP binding and activates GTPase: cytoskeletal participation in neuronal signal transduction. Biochemistry 33: 9800–9805PubMedCrossRefGoogle Scholar
  32. Rudolph SA, Hegstrand LR, Greengard P, Malawista SE (1979) The interaction of colchicine with hormone-sensitive adenylate cyclase in human leukocytes. Mol Pharmacol 16: 805–812PubMedGoogle Scholar
  33. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509–522PubMedGoogle Scholar
  34. Schulman H (1984) Differential phosphorylation of MAP-2 stimulated by calcium-calmodulin and cyclic AMP. Mol Cell Biol 4: 1175–1178PubMedGoogle Scholar
  35. Stephens RE (1986) Membrane tubulin. Biol Cell 57: 95–110PubMedCrossRefGoogle Scholar
  36. Sulser F (1984) Antidepressant treatments and regulation of norepinephrine- receptor-coupled adenylate cyclase systems in brain. Adv Biochem Psychopharmacol 39: 249–261PubMedGoogle Scholar
  37. Wang N, Rasenick MM (1991) Tubulin-G protein interactions involve microtubule polymerization domains. Biochemistry 30: 10957–10965PubMedCrossRefGoogle Scholar
  38. Wang N, Yan K, Rasenick MM (1990) Tubulin binds specifically to the signal-transducing proteins, Gsa and GioCj. J Biol Chem 265: 1239–1242.Google Scholar
  39. Yamamoto H, Tomita U, Mikuni M, Kobayasi I, Kagaya A, Katada T, Ui M, Takahashi K (1992) Direct activation of purified Go-type GTP binding protein by tricyclic antidepressants. Neurorosci Lett 139: 194–196CrossRefGoogle Scholar
  40. Yan K, Greene E, Belga F, Rasenick MM (1996) Synaptic membrane G proteins are complexed with tubulin in situ. J Neurochem 66: 1489–1495PubMedCrossRefGoogle Scholar
  41. Zemlan FP, Garver DL (1990) Depression and antidepressant therapy: receptor dy¬namics. Prog Neuropsychopharmacol Biol Psychiatry 14: 503–523PubMedCrossRefGoogle Scholar
  42. Zisapel N, Levi M, Gozes I (1980) Tubulin: an integral protein of mammalian synaptic vesicle membranes. J Neurochem 34: 26–32PubMedCrossRefGoogle Scholar
  43. Zor U (1983) Role of cytoskeletal organization in the regulation of adenylate cyclase- cyclic adenosine monophosphate by hormones. Endocr Rev 4: 1–21PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1998

Authors and Affiliations

  • Shinichi Hatta
    • 1
  • Hideyo Ohshika
    • 1
  1. 1.Department of Pharmacology, School of MedicineSapporo Medical UniversitySapporo, Hokkaido 060Japan

Personalised recommendations